Quipazine: A Long-Standing Enigma in Psychedelic Research
The “psychedelic drug” label appears to define a clear-cut category. However, there are lesser-known research chemicals that depict more diffuse boundaries in this classification.
Chemistry - Page 3
MindMed and Liechti Lab to Conduct the First Clinical Trial Combining LSD and MDMA
Researchers will examine whether MDMA can offset some of the negative side effects of LSD in a therapeutic setting.
The Role of the Claustrum in the Psychedelic Experience
Brain scans show that psilocybin modulates claustrum connectivity in brain networks.
Examining the Cognitive Neuroscience of Psychedelics
The new REBUS model helps explain the subjective and neurochemical effects of psychedelics on the brain.
Solved: The Crystal Structure of the Iodide Salts of DMPT and DMALT
The catalog of compounds for use in psychedelic drug research continues to grow.
Crystal Structures of Hydrofumarate Salts of DMT Analogues EPT and MALT Solved
The researchers hope these compounds “will expand the universe of options for improving mental health.”
Study Finds Aeruginascin Metabolite 4-HO-TMT is Active at the Serotonin 5-HT2A Receptor
Surprisingly, 4-HO-TMT has binding affinity similar to psilocin at 5-HT2A.
What is Salvia divinorum?
The primary active compound in this plant is more potent than LSD.
Solved: The Crystal Structure of N-Methyl-N-Propyltryptamine (MPT)
This structural analog of DMT is an understudied compound presenting new options for psychedelic drug development.
Psychedelics May Relieve Chronic Pain Via Changes in Brain Neuroplasticity
Using psychedelics to treat chronic pain is understudied yet full of potential.